# Anaergia (ANRG.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Industrials / Commercial Services & Supplies. Price C$2.70, market value C$466 million.

## Valuation
- **P/E (trailing): 30.0×** (5-yr avg 56.5×, 3-yr avg 56.5×). Anaergia trades at 30.0× trailing earnings, well below its own five-year average of 56.5×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 27.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.24**. A PEG of 0.24 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.9×**. Each dollar of revenue is priced at 1.9×.
- **EV / EBITDA: 56.3×**. Enterprise value is 56.3× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: -1.0%** (5-yr avg -180.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.
- **Earnings yield: 3.3%**. The inverse of the P/E: 3.3% of the price is earned each year.

## Profitability
- **Gross margin: 20.4%**. Anaergia keeps 20.4% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -2.9%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: 3.9%**. 3.9% of each dollar of sales reaches the bottom line.
- **Return on equity: -15.0%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 14.0%**. Return on all capital, debt included, is 14.0%.
- **Return on assets: 6.5%**. Each dollar of assets produces 6.5% of profit.

## Growth
- **Revenue growth (1 yr): 61.4%** (3-yr 3.4%/yr, 5-yr 7.1%/yr). Revenue grew 61.4% over the last year, against 7.1% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 112.9%**. Earnings per share rose 112.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Net debt / EBITDA: 2.5×**. It would take 2.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: -1.4×**. Operating profit covers interest only -1.4×: fragile.
- **Current ratio: 0.72** (quick 0.65). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.64**. A Z-score of 1.64 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Anaergia does not currently pay a dividend, but it returned -1.4% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): -13.2%** (YTD 19.5%, 3-mo -0.4%). The shares are down 13.2% over twelve months including dividends.
- **From 52-week high: -23.1%** (42.1% above the low). Trading 23% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 63**. An RSI of 63 is neutral.
- **Beta (1 yr): 1.40** (volatility 60%). Beta of 1.40 against the S&P/TSX Composite: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ANRG.TO · Page: https://foliofundamentals.com/stocks/anrg.to

Not investment advice.